Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Prudential PLC Regulatory Filings 2017

Aug 21, 2017

4668_prs_2017-08-21_d2352fb6-32a0-499a-a8bf-f5478b6a3757.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5589O

Prudential PLC

21 August 2017

Prudential PLC

21 August 2017

Publication of Supplementary Prospectus

The following supplementary prospectus has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 21 August, 2017 (the "Supplementary Prospectus") to the prospectus dated 24 May, 2017 (the "Prospectus"), relating to Prudential PLC's £6,000,000,000 Medium Term Note Programme.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/5589O_-2017-8-21.pdf

A copy of the Supplementary Prospectus and the documents incorporated by reference therein will be submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

This site is not provided for, or directed at, persons in the United States.  If you are viewing this page from the United States, you should exit this section of the site.

Prudential plc is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America.

Enquiries to:

Media: Investors/Analysts:
Jonathan Oliver

Tom Willetts
+44 (0)20 7548 3719

+44 (0)20 7548 2776
Raghu Hariharan

Richard Gradidge

William Elderkin
+44 (0)20 7548 2871

+44 (0)20 7548 3860

+44 (0) 20 3480 5590

DISCLAIMER

Please note that the information contained in the Supplementary Prospectus and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus (as supplemented by the Supplementary Prospectus) is not addressed. Prior to relying on the information contained in the Prospectus (as supplemented by the Supplementary Prospectus) you must ascertain from the Prospectus (as supplemented by the Supplementary Prospectus) whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Neither the Prospectus nor the Supplementary Prospectus constitutes an offer of securities for sale in the United States. The securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, or under any relevant securities laws of any state of the United States of America and may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. Persons, subject to certain limited exemptions.

This information is provided by RNS

The company news service from the London Stock Exchange

END

PSPSEIFFFFWSELA